drugset
drugset / Trial / NCT05258721

Efficacy of ClōSYS® Sensitive Fluoride Toothpaste and ClōSYS® Sensitive Rinse Regimen on MGI, PI and BOP

NCT05258721 ↗

Phase 2 Completed 60 enrolled Rowpar Pharmaceuticals, Inc.
NaSingle-groupOpen-labelTreatment

Summary

90-day, self-controlled, longitudinal, non-blinded clinical trial which will measure changes in clinical parameters in participants with gingivitis and Stage I or II periodontitis who apply ClōSYS® Sensitive Fluoride Toothpaste and ClōSYS® Sensitive Rinse.

Timeline

Start
2021-07-06
Primary completion
2022-10-31
Completion
2022-10-31

Drugs

EvaluationDrugModalityDoseRoute
Subject fluoride ion Small molecule 0.13 % —
Subject stabilized chlorine dioxide Unknown 0.12 % —

Indications

gingivitis periodontitis